New Key Statistics Module, Z-Score and F-Score
NAS:BIIB Key Ratios
| Market Cap $ M | 27,982.68 |
| Enterprise Value $ M | 33,962.82 |
| P/E(ttm) | 24.12 |
| PE Ratio without NRI | 13.19 |
| Forward PE Ratio | 12.53 |
| Price/Book | 1.88 |
| Price/Sales | 2.81 |
| Price/Free Cash Flow | 22.57 |
| Price/Owner Earnings | 87.07 |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 9,835.00 |
| EPS (TTM) $ | 7.98 |
| Beneish M-Score | -2.31 |
| 10-y EBITDA Growth Rate % | 2.20 |
| 5-y EBITDA Growth Rate % | -15.60 |
| y-y EBITDA Growth Rate % | -53.10 |
| EV-to-EBIT | 22.00 |
| EV-to-EBITDA | 16.66 |
| PEG | -- |
| Shares Outstanding M | 145.36 |
| Net Margin (%) | 11.81 |
| Operating Margin % | 18.62 |
| Pre-tax Margin (%) | 13.19 |
| Quick Ratio | 1.26 |
| Current Ratio | 2.00 |
| ROA % (ttm) | 4.49 |
| ROE % (ttm) | 8.18 |
| ROIC % (ttm) | 8.56 |
| Dividend Yield % | -- |
| Altman Z-Score | 3.01 |
| Piotroski F-Score | 3.00 |
| Positive ROA | Y |
| Positive CFROA | Y |
| Higher ROA y-y | N |
| Cash flow > Earnings | Y |
| Lower Leverage y-y | N |
| Higher Current Ratio y-y | N |
| Less Shares Outstanding y-y | N |
| Gross Margin Increase y-y | N |
| Higher Asset Turnover y-y | N |
BIIB Number of Guru Trades
BIIB Volume of Guru Trades
Gurus Latest Trades with NAS:BIIB
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:BIIB is held by these investors
Total 5
Biogen Inc Insider Transactions
No Available Data
News about NAS:BIIB
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers